Virus-like particle (VLP) technology is a very powerful method for developing vaccines. VLPs mimic the conformation of authentic native viruses without being infectious, since they do not carry any viral genetic material. When presented within a host immune system, VLPs evoke effective immune responses without triggering the side effects associated with the native virus.



Comments are closed